Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120064) titled 'Whole-Brain Radiotherapy Versus Whole-Brain Radiotherapy with simultaneous integrated boost in Non-Small Cell Lung Cancer (NSCLC) with Multiple (>=5) Brain Metastases' on March 9.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital of Xiamen University
Condition:
Non-small cell lung cancer (NSCLC) with multiple brain metastases
Intervention:
Intervention Group:hippocampal-avoidant whole-brain radiotherapy +simultaneous integrated boost
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-25
Target Sample Size: Interventio...